Cargando…

Inhibition of Histone Deacetylase Impacts Cancer Stem Cells and Induces Epithelial-Mesenchyme Transition of Head and Neck Cancer

The genome is organized and packed into the nucleus through interactions with core histone proteins. Emerging evidence suggests that tumors are highly responsive to epigenetic alterations that induce chromatin-based events and dynamically influence tumor behavior. We examined chromatin organization...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giudice, Fernanda S., Pinto, Decio S., Nör, Jacques E., Squarize, Cristiane H., Castilho, Rogerio M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603970/ https://www.ncbi.nlm.nih.gov/pubmed/23527004 http://dx.doi.org/10.1371/journal.pone.0058672

Ejemplares similares

Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy
por: Castilho, Rogerio M., et al.
Publicado: (2017)

NFκB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC)()
por: Almeida, Luciana O., et al.
Publicado: (2013)

Profiling the Behavior of Distinct Populations of Head and Neck Cancer Stem Cells
por: Almeida, Luciana O., et al.
Publicado: (2016)

Targeting histone deacetylase and NFκB signaling as a novel therapy for Mucoepidermoid Carcinomas
por: Wagner, Vivian P., et al.
Publicado: (2018)

Histone Modification on Parathyroid Tumors: A Review of Epigenetics
por: Conti de Freitas, Luiz C., et al.
Publicado: (2022)

Histone Deacetylase Inhibitors Induce Epithelial-to-Mesenchymal Transition in Prostate Cancer Cells
por: Kong, Dejuan, et al.
Publicado: (2012)

A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract Cancer
por: Sakamoto, Takuya, et al.
Publicado: (2016)

The translational significance of epithelial-mesenchymal transition in head and neck cancer
por: Graves, Christian A, et al.
Publicado: (2014)

Epithelial-to-Mesenchymal Transition in the Pathogenesis and Therapy of Head and Neck Cancer
por: Thierauf, Julia, et al.
Publicado: (2017)

Histone Deacetylase Inhibitor Therapy in Epithelial Ovarian Cancer
por: Takai, Noriyuki, et al.
Publicado: (2010)

Targeting histone deacetylase-3 blocked epithelial-mesenchymal plasticity and metastatic dissemination in gastric cancer
por: Wu, Sheng-Mao, et al.
Publicado: (2022)

Reolysin and Histone Deacetylase Inhibition in the Treatment of Head and Neck Squamous Cell Carcinoma
por: Jaime-Ramirez, Alena C., et al.
Publicado: (2017)

Epigenetic reprogramming of epithelial mesenchymal transition in triple negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors
por: Su, Yanrong, et al.
Publicado: (2018)

Rac1 Is Required for Epithelial Stem Cell Function during Dermal and Oral Mucosal Wound Healing but Not for Tissue Homeostasis in Mice
por: Castilho, Rogerio M., et al.
Publicado: (2010)

Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer
por: Lee, Jaewang, et al.
Publicado: (2020)

Mitochondrial dysfunction and epithelial to mesenchymal transition in head neck cancer cell lines
por: Greier, Maria Carmo, et al.
Publicado: (2022)

Unlocking the chromatin of adenoid cystic carcinomas using HDAC inhibitors sensitize cancer stem cells to cisplatin and induces tumor senescence
por: Almeida, Luciana O., et al.
Publicado: (2017)

Skin wound healing triggers epigenetic modifications of histone H4
por: Nascimento-Filho, Carlos H. V., et al.
Publicado: (2020)

Histone deacetylase 3 promotes alveolar epithelial–mesenchymal transition and fibroblast migration under hypoxic conditions
por: Jeong, Sung Hwan, et al.
Publicado: (2022)

Cetuximab promotes epithelial to mesenchymal transition and cancer associated fibroblasts in patients with head and neck cancer
por: Schmitz, Sandra, et al.
Publicado: (2015)

Slug Is A Surrogate Marker of Epithelial to Mesenchymal Transition (EMT) in Head and Neck Cancer
por: Steinbichler, T. B., et al.
Publicado: (2020)

Relationship between Tumor Budding and Partial Epithelial–Mesenchymal Transition in Head and Neck Cancer
por: Okuyama, Kohei, et al.
Publicado: (2023)

The Role of Exosomes in Epithelial–to-Mesenchymal Transition and Cell Functional Properties in Head and Neck Cancer
por: Mastronikolis, Nicholas S., et al.
Publicado: (2023)

Indications and pitfalls of immunohistochemistry in head and neck cancer
por: Caly, Décio de Natale, et al.
Publicado: (2015)

Histone deacetylase inhibitors reinforce the phenotypical markers of breast epithelial or mesenchymal cancer cells but inhibit their migratory properties
por: Wawruszak, Anna, et al.
Publicado: (2019)

Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers
por: Sanaei, Masumeh, et al.
Publicado: (2019)

Histone deacetylase 6 in cancer
por: Li, Ting, et al.
Publicado: (2018)

The epigenetic modifier trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial–mesenchymal transition of lens epithelial cells
por: Chen, X, et al.
Publicado: (2013)

Histone deacetylase 6 inhibition counteracts the epithelial–mesenchymal transition of peritoneal mesothelial cells and prevents peritoneal fibrosis
por: Xu, Liuqing, et al.
Publicado: (2017)

Periodontal disease affects oral cancer progression in a surrogate animal model for tobacco exposure
por: Spuldaro, Tobias R., et al.
Publicado: (2022)

Histone Deacetylases and Histone Deacetylase Inhibitors in Neuroblastoma
por: Phimmachanh, Monica, et al.
Publicado: (2020)

Evidence for Epithelial-Mesenchymal Transition in Cancer Stem Cells of Head and Neck Squamous Cell Carcinoma
por: Chen, Chao, et al.
Publicado: (2011)

Histone deacetylases as new therapy targets for platinum-resistant epithelial ovarian cancer
por: Pchejetski, Dmitri, et al.
Publicado: (2015)

Accelerated Wound Healing by mTOR Activation in Genetically Defined Mouse Models
por: Squarize, Cristiane H., et al.
Publicado: (2010)

Sensitizing mucoepidermoid carcinomas to chemotherapy by targeted disruption of cancer stem cells
por: Guimarães, Douglas M., et al.
Publicado: (2016)

Trichostatin A, a histone deacetylase inhibitor, suppresses proliferation and epithelial–mesenchymal transition in retinal pigment epithelium cells
por: Xiao, Wei, et al.
Publicado: (2014)

Requirement of Histone Deacetylase 6 for Interleukin-6 Induced Epithelial-Mesenchymal Transition, Proliferation, and Migration of Peritoneal Mesothelial Cells
por: Shi, Yingfeng, et al.
Publicado: (2021)

Metformin and histone deacetylase inhibitor based anti-inflammatory nanoplatform for epithelial-mesenchymal transition suppression and metastatic tumor treatment
por: Jiang, Tianze, et al.
Publicado: (2022)

Acetylation and Histone Deacetylase Inhibitors in Cancer
por: Kortenhorst, Madeleine S. Q., et al.
Publicado: (2006)

Histone Deacetylases and Their Inhibitors in Cancer Epigenetics
por: Hassell, Kelly N.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8ivjn3b6luc7u6ho859t1tdjjr